Unravelling the general properties of siRNAs: strength in numbers and lessons from the past.
Hall
Jonathan
J
Novartis Pharma AG, Department of Functional Genomics, WSJ88.431, CH-4002 Basel, Switzerland. jonathan.hall@pharma.novartis.com
D000818:Animals; D017173:Caenorhabditis elegans; D004331:Drosophila melanogaster; D016678:Genome; D006801:Humans; D035683:MicroRNAs / Q000378:metabolism; D008957:Models, Genetic; D009841:Oligonucleotides / Q000737:chemistry; D016376:Oligonucleotides, Antisense / Q000737:chemistry; D034741:RNA, Small Interfering / Q000737:chemistry* / Q000378:metabolism
D035683:MicroRNAs; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense; D034741:RNA, Small Interfering